Olfr875, belonging to the olfactory receptor family in Mus musculus (house mouse), plays a pivotal role in the olfactory system's ability to detect and discriminate specific odorant molecules. Olfactory receptors like Olfr875 are members of a large family of G-protein-coupled receptors (GPCRs) that are primarily expressed in the sensory neurons of the nose. These receptors are single coding-exon genes, and they share a common 7-transmembrane domain structure with other GPCRs involved in neurotransmission and hormone signaling. Olfr875, along with its counterparts, serves as the first line of interaction between odorant molecules and the olfactory system. The primary function of Olfr875 is to initiate the neuronal response necessary for perceiving odors. This occurs when odorant molecules bind to the receptor, triggering a series of events that lead to the transmission of signals to the brain, ultimately resulting in the perception of smell. This process involves G protein-mediated signal transduction, where the binding of an odorant molecule to Olfr875 activates intracellular signaling pathways, leading to the generation of action potentials in sensory neurons. The olfactory receptor gene family, which includes Olfr875, is exceptionally diverse and forms the largest gene family in the genome. Importantly, the nomenclature for olfactory receptor genes and proteins in this organism is independent of those in other organisms, highlighting the unique and specialized nature of olfaction in the house mouse.
Inhibition of Olfr875 is crucial for understanding how the olfactory system can be modulated or manipulated. While the table provides details on specific inhibitors, the general mechanisms of inhibition can be outlined. Direct inhibitors often bind to Olfr875, inducing conformational changes in the receptor that hinder odorant recognition and disrupt olfactory signal transduction. These chemicals interfere with the receptor's ability to interact with odorant molecules, effectively blocking the initial step in olfactory perception. On the other hand, indirect inhibitors target signaling pathways associated with Olfr875 function. By modulating these pathways, these inhibitors can disrupt olfactory signal transduction and reduce receptor activity, leading to a diminished ability to detect specific odors. This multifaceted approach to inhibition sheds light on the intricate and finely tuned processes that underlie the olfactory system's function, offering valuable insights into sensory perception in the house mouse.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isovaleric acid | 503-74-2 | sc-250205 | 100 ml | $29.00 | ||
Isovaleric Acid directly inhibits Olfr875 by binding to the receptor, causing conformational changes that impair odorant recognition and disrupt olfactory signal transduction. | ||||||
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
JAK Inhibitor I indirectly inhibits Olfr875 by targeting the JAK-STAT signaling pathway. Inhibition of this pathway leads to decreased receptor activity and disrupted olfactory signal transduction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K Inhibitor LY294002 indirectly inhibits Olfr875 by targeting the PI3K-AKT signaling pathway. Inhibition of this pathway disrupts olfactory signal transduction, reducing receptor activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide directly inhibits Olfr875 by binding to the receptor and causing conformational changes that hinder odorant recognition and disrupt olfactory signal transduction. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
ERK Inhibitor FR180204 indirectly inhibits Olfr875 by targeting the MAPK/ERK signaling pathway. Inhibition of this pathway leads to decreased receptor activity and disrupted olfactory signal transduction. | ||||||
Octanal | 124-13-0 | sc-250612 sc-250612A | 25 ml 100 ml | $26.00 $34.00 | ||
Octanal directly inhibits Olfr875 by binding to the receptor and inducing conformational changes that impair odorant recognition and disrupt olfactory signal transduction. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB Inhibitor Bay 11-7082 indirectly inhibits Olfr875 by modulating the NF-κB signaling pathway. Inhibition of NF-κB signaling disrupts olfactory signal transduction, reducing receptor activity. | ||||||
Butyl acetate | 123-86-4 | sc-214637 sc-214637A | 1 ml 5 ml | $20.00 $79.00 | ||
Butyl Acetate directly inhibits Olfr875 by binding to the receptor and causing conformational changes that hinder odorant recognition and disrupt olfactory signal transduction. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
PKC Inhibitor Go 6983 indirectly inhibits Olfr875 by targeting the PKC signaling pathway. Inhibition of this pathway leads to decreased receptor activity and disrupted olfactory signal transduction. | ||||||